ALX Oncology Holdings Inc (ALXO) stock
ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.97−0.03 (-3.47%)
Close on Nov 18, 2026Market cap $134.14MP/E –Yield –
ALX Oncology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
ALX Oncology's price to sales ratio was 34.3× on Oct 30, 2020.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Oct 30, 2020 | 34.3× | – |
See a number that looks wrong?